- Home
- MITT vs CATX Comparison
MITT vs CATX Comparison
Compare MITT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITT
- CATX
- Stock Information
- Founded
- MITT 2011
- CATX 1983
- Country
- MITT United States
- CATX United States
- Employees
- MITT N/A
- CATX N/A
- Industry
- MITT Real Estate Investment Trusts
- CATX Medical/Dental Instruments
- Sector
- MITT Real Estate
- CATX Health Care
- Exchange
- MITT Nasdaq
- CATX Nasdaq
- Market Cap
- MITT 191.8M
- CATX 183.2M
- IPO Year
- MITT 2011
- CATX N/A
- Fundamental
- Price
- MITT $7.48
- CATX $2.22
- Analyst Decision
- MITT Buy
- CATX Strong Buy
- Analyst Count
- MITT 5
- CATX 11
- Target Price
- MITT $8.40
- CATX $15.30
- AVG Volume (30 Days)
- MITT 249.3K
- CATX 531.3K
- Earning Date
- MITT 03-03-2025
- CATX 03-26-2025
- Dividend Yield
- MITT 10.68%
- CATX N/A
- EPS Growth
- MITT N/A
- CATX N/A
- EPS
- MITT 1.23
- CATX N/A
- Revenue
- MITT $87,547,000.00
- CATX $1,454,000.00
- Revenue This Year
- MITT N/A
- CATX N/A
- Revenue Next Year
- MITT $4.86
- CATX $1.15
- P/E Ratio
- MITT $6.09
- CATX N/A
- Revenue Growth
- MITT 37.53
- CATX 1.40
- 52 Week Low
- MITT $5.44
- CATX $2.19
- 52 Week High
- MITT $7.95
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- MITT 49.81
- CATX 33.93
- Support Level
- MITT $7.51
- CATX $2.32
- Resistance Level
- MITT $7.91
- CATX $2.62
- Average True Range (ATR)
- MITT 0.17
- CATX 0.18
- MACD
- MITT -0.03
- CATX 0.00
- Stochastic Oscillator
- MITT 36.76
- CATX 4.84
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long-term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government sponsored enterprise.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.